Power of integrating PBPK with PBBM (PBPK-BM): a single model predicting food effect, gender impact, drug-drug interactions and bioequivalence in fasting & fed conditions
Authors:
- 3 April 2023
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 53 (4) , 260-278
Abstract
Over the past few years, PBPK and PBBM modelling have proven their significance in drug development. PBPK modelling is traditionally used to predict drug-drug interactions, exposures in special populations whereas PBBM modelling is a part of PBPK modelling that is used for a range of biopharmaceutics applications.Because of these differences in utilities, often PBPK and PBBM models are developed separately. When both models are combined, they serve multiple purposes through unified model. In the present case, an integrated PBPK-PBBM model for an IR product has been utilised for bioequivalence prediction in fasting & fed conditions, evaluating gender impact and food effect, prediction of drug-drug interactions.Model was built using physicochemical properties, enzymes and transporter kinetics, bio-predictive dissolution and has been validated with passing and failed pilot BE studies. The validated model predicted pivotal bioequivalence outcomes in fasting & fed conditions accurately, predicted gender impact and food effect in line with literature. Drug-drug interactions arising from transporter and metabolising enzymes were predicted accurately.Overall, this work demonstrates the utility of combining PBPK and PBBM model that can yield a single model which can be used for multiple purposes, regulatory justifications and can reduce regulatory review timelines.Keywords
Funding Information
- Dr. Reddy’s laboratories Ltd
This publication has 19 references indexed in Scilit:
- Establishing virtual bioequivalence and clinically relevant specifications using in vitro biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. case example: NaproxenEuropean Journal of Pharmaceutical Sciences, 2020
- Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link—a Workshop Summary ReportThe AAPS Journal, 2019
- Prediction of ARA/PPI Drug-Drug Interactions at the Drug Discovery and Development InterfaceJournal of Pharmaceutical Sciences, 2019
- PBPK modeling and simulation in drug research and developmentActa Pharmaceutica Sinica B, 2016
- In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug InteractionsPharmaceutical Research, 2011
- Prediction of time-dependent CYP3A4 drug–drug interactions by physiologically based pharmacokinetic modelling: Impact of inactivation parameters and enzyme turnoverEuropean Journal of Pharmaceutical Sciences, 2011
- Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory ReviewClinical Pharmacology & Therapeutics, 2010
- Rate-Limiting Steps of Oral Absorption for Poorly Water-Soluble Drugs in Dogs; Prediction from a Miniscale Dissolution Test and a Physiologically-Based Computer SimulationPharmaceutical Research, 2008
- Gemfibrozil and its glucuronide inhibit the hepatic uptake of pravastatin mediated by OATP1B1Xenobiotica, 2007
- Sequential Metabolism Is Responsible for Diltiazem-Induced Time-Dependent Loss of CYP3ADrug Metabolism and Disposition, 2007